Shanghai: Female employees can apply for a subsidy at a rate of 50% of social insurance contributions during maternity leave to encourage childbirth.

The Shanghai Municipal Government Office issued a notice on "Several Measures to Accelerate the Improvement of the Fertility Support Policy System and Promote the Construction of a Fertility-Friendly Society". The measures include establishing a fertility subsidy system in conjunction with Shanghai's economic and social development and budgetary situation. A reasonable shared cost mechanism will be established, allowing units that meet certain criteria to apply for a subsidy at a rate of 50% for the social insurance contributions made by the unit during the maternity leave and childbirth leave of their female employees. The policy of special additional deductions for personal income tax related to the care of children under three years old and education will be implemented. At the same time, the differentiated housing policy for families with multiple children will be advanced.

AASTOCKSDec 31, 2024 11:59

BASECARE-B (02170): Zhao has been nominated as a non-executive Director.

BASECARE-B (02170) announces that the Board of Directors has reviewed and approved the re-election of Jiang Junchao for...

Zhitong FinanceDec 30, 2024 22:53

Suzhou Basecare Enters Assisted Reproduction Cooperation Contract

MT NewswiresDec 24, 2024 18:56

BASECARE-B (02170.HK) has signed a Global Strategy cooperation agreement with Qinghua Medical.

On December 24, Glonghui reported that BASECARE-B (02170.HK) announced that the group has signed a Global Strategy cooperation agreement with Shanghai Jinghua Medical Management Co., Ltd. ("Jinghua Medical") on December 24, 2024. This cooperation agreement will be effective from the date of signing and will last for five years. Under the Global Strategy cooperation agreement, the group will provide Jinghua Medical with AI-based one-stop multi-scenario solutions covering areas such as urological testing, embryo culture, refrigerated storage, and complex genetic disease diagnosis and treatment, aiming to create an internationally leading benchmark center for Assisted Reproduction. The scope of cooperation under the Global Strategy agreement includes: (i) Jinghua

Gelonghui FinanceDec 24, 2024 17:40

Highly resilient! Leading CRO companies have stabilized their fundamentals, but the shadow of the biosafety bill may still linger next year | Year-end review.

① In 2024, the USA Biodefense Act will disrupt CROs throughout the year and may continue next year; ② In the first three quarters of this year, over half of listed companies experienced revenue growth, and leading CROs demonstrated resilience; ③ Research on popular targets such as ADC, GLP-1, and bispecific antibodies will continue to be hot; ④ In 2025, the performance of leading CROs and small to medium enterprises may further diverge.

cls.cnDec 24, 2024 17:16

Express News | The USA Biological Security Act was not included in the CR bill.

BreakingsDec 18, 2024 15:53